Literature DB >> 1636866

Magnetic resonance imaging evaluation of the patellar tendon after use of its central one-third for anterior cruciate ligament reconstruction.

S D Coupens1, C K Yates, C Sheldon, C Ward.   

Abstract

Magnetic resonance imaging was used to evaluate the remaining patellar tendon after its central one-third had been harvested for anterior cruciate ligament reconstruction. Twenty patients were studied at either 6 weeks, 4, 6, 9, or 18 months postoperatively. The average thickness, width, cross-sectional area, and signal intensity of the operated and contralateral non-operated tendons were calculated and compared for each magnetic resonance imaging scan. A significant increase in the thickness was noted at all periods of followup, but no change in width occurred despite the defect being closed at the time of surgery. High signal intensity was present in the early periods, which signified edema and scar tissue. Signal intensity decreased at subsequent follow-up periods until at 18 months the operated tendon appeared normal. These findings indicate that the patellar tendon has the potential to regenerate and remodel in the postoperative period.

Entities:  

Mesh:

Year:  1992        PMID: 1636866     DOI: 10.1177/036354659202000317

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  14 in total

Review 1.  [MRI after meniscus and cruciate ligament surgery].

Authors:  J Kramer; M Breitenseher; A Stöger; H Huber; A Scheurecker
Journal:  Radiologe       Date:  2006-01       Impact factor: 0.635

Review 2.  MR imaging evaluation of the postoperative knee: ligaments, menisci, and articular cartilage.

Authors:  Lawrence M White; Josef Kramer; Michael P Recht
Journal:  Skeletal Radiol       Date:  2005-06-21       Impact factor: 2.199

3.  The reharvested patellar tendon has the potential for ligamentization when used for anterior cruciate ligament revision surgery.

Authors:  Sven Stener; Lars Ejerhed; Tomas Movin; Ninni Sernert; Nikos Papadogiannakis; Jüri Kartus
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-02-05       Impact factor: 4.342

4.  Evaluation of knee stability with use of a robotic system.

Authors:  Savio L-Y Woo; Matthew B Fisher
Journal:  J Bone Joint Surg Am       Date:  2009-02       Impact factor: 5.284

Review 5.  Bioreactor design for tendon/ligament engineering.

Authors:  Tao Wang; Bruce S Gardiner; Zhen Lin; Jonas Rubenson; Thomas B Kirk; Allan Wang; Jiake Xu; David W Smith; David G Lloyd; Ming H Zheng
Journal:  Tissue Eng Part B Rev       Date:  2012-11-19       Impact factor: 6.389

6.  The course of the patellar tendon after reharvesting its central third for ACL revision surgery: a long-term clinical and radiographic study.

Authors:  Mattias Lidén; Lars Ejerhed; Ninni Sernert; Ake Bovaller; Jon Karlsson; Jüri Kartus
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2006-09-02       Impact factor: 4.342

7.  Healing of donor site in bone-tendon-bone ACL reconstruction accelerated with plasma rich in growth factors: a randomized clinical trial.

Authors:  Roberto Seijas; Marta Rius; Oscar Ares; Montserrat García-Balletbó; Iván Serra; Ramón Cugat
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-11-27       Impact factor: 4.342

8.  Healing of the patellar tendon after harvesting of its mid-third for anterior cruciate ligament reconstruction and evolution of the unclosed donor site defect.

Authors:  E Adriani; P P Mariani; G Maresca; N Santori
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  1995       Impact factor: 4.342

9.  Donor-site morbidity after harvest of a bone-tendon-bone patellar tendon autograft.

Authors:  D Kohn; A Sander-Beuermann
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  1994       Impact factor: 4.342

10.  Anterior cruciate ligament patellar tendon reconstruction: it is probably better to leave the tendon defect open!

Authors:  G Cerullo; G Puddu; E Gianní; A Damiani; F Pigozzi
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  1995       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.